GORDON SCHUTZE to Drug Resistance, Bacterial
This is a "connection" page, showing publications GORDON SCHUTZE has written about Drug Resistance, Bacterial.
Connection Strength
0.124
-
Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USA. J Antimicrob Chemother. 2006 Jun; 57(6):1240-3.
Score: 0.053
-
In vitro activity of telithromycin against macrolide-susceptible and macrolide-resistant pharyngeal isolates of group A streptococci in the United States. Antimicrob Agents Chemother. 2005 Jun; 49(6):2487-9.
Score: 0.050
-
Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics. 2004 Mar; 113(3 Pt 1):443-9.
Score: 0.011
-
Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics. 2002 Jul; 110(1 Pt 1):1-6.
Score: 0.010